Drugs / LR-PRP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06040203 | Mar 2023 → Mar 2027 expected | epicondylitis | Rizzoli Orthopaedic Institute | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LR-PRP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06040203 ↗ |
| Known as | Leukocyte-rich Platelet rich plasma | “Injection of autologous leukocyte rich platelet rich plasma (LR-PRP)” NCT06040203 ↗ |
| Route | Other | “single eco-guided injection of Autologous LR-PRP” NCT06040203 ↗ |